Carlyle Acquires Tarrytown Expocare Pharmacy from Sheridan Capital Partners

Carlyle Acquires Tarrytown Expocare Pharmacy from Sheridan Capital Partners

November 14, 2025

Healthcare Services

Funds managed by global investment firm Carlyle have acquired Tarrytown Expocare Pharmacy from Sheridan Capital Partners, with Sheridan retaining a minority stake. Carlyle plans to support Tarrytown’s expansion of its specialized long-term care pharmacy services for the IDD and behavioral health communities across the U.S.; financial terms were not disclosed.

Tarrytown Expocare Pharmacy Acquires Greater Boston Long Term Care Pharmacy

December 16, 2024

Healthcare Services

Tarrytown Expocare Pharmacy, a national long-term care pharmacy focused on IDD and behavioral health, has acquired Greater Boston Long Term Care Pharmacy to establish a Massachusetts presence. The deal, supported by Sheridan Capital Partners and advised on the sell-side by M&A Healthcare Advisors, adds a regional location to Tarrytown's platform and aims to expand services to group homes and assisted living communities across the Commonwealth.

Carlyle and Consonance Partner with Orsini Specialty Pharmacy

February 11, 2022

Healthcare Services

Funds managed by global investment firm Carlyle have joined Consonance Capital Partners in a strategic partnership with Orsini Specialty Pharmacy to support expansion of patient access and high-touch support services for rare diseases, gene therapies and complex conditions. Terms were not disclosed; the investment is intended to strengthen Orsini’s service offerings for patients, manufacturers and payors and accelerate growth.

Medicure Inc. Acquires Marley Drug, Inc.

December 15, 2020

Healthcare Services

Medicure Inc., through its wholly-owned U.S. subsidiary Medicure Pharma Inc., agreed to acquire 100% of Marley Drug, Inc., a specialty mail-order pharmacy based in North Carolina, for an upfront USD $6.3 million plus contingent payments. Marley serves over 30,000 customers nationwide, generated approximately $7.0 million of revenue and more than $1.7 million of EBITDA for the 12 months ended October 31, 2020, and the acquisition expands Medicure's direct-to-patient distribution and specialty pharmacy capabilities in the United States.

Carlyle and PAI Partners Acquire Theramex from CVC Capital Partners

March 28, 2022

Pharmaceuticals

Global private equity firms Carlyle and PAI Partners have agreed to acquire Theramex, a London-based specialty pharmaceuticals company focused on women's health, from CVC Capital Partners VI. The new owners plan to accelerate Theramex's international expansion and broaden its women's health product suite to drive further organic and inorganic growth.

Carlyle Acquires Abingworth to Expand Global Healthcare & Life Sciences Investing

August 3, 2022

Healthcare Services

Global investment firm Carlyle has acquired Abingworth, a transatlantic life sciences investment firm with about $2 billion in assets under management, to broaden Carlyle's healthcare franchise and capabilities across venture to buyouts. The deal brings Abingworth's specialized team and clinical co-development expertise into Carlyle and establishes Launch Therapeutics, an operating company to accelerate late-stage clinical development; terms were not disclosed.